Glenmark Pharmaceuticals appoints Ajay Jajoo as Group VP & Global Corporate Controller

Prior to joining Glenmark Pharmaceuticals, Jajoo served as President and Chief Financial Officer at Deepak Phenolics Limited

e4m by e4m Staff
Published: Jun 2, 2026 2:19 PM  | 1 min read
Ajay Jajoo
  • e4m Twitter
  • Ajay Jajoo has been appointed as Group Vice President & Global Corporate Controller at Glenmark Pharmaceuticals.
  • He announced his new role on LinkedIn, highlighting the company's focus on innovative drug development and stakeholder value creation.
  • Prior to Glenmark, Jajoo was President and CFO at Deepak Phenolics Limited and has held senior roles in various industries, including Sterlite Technologies and Vedanta Ltd.
  • His extensive experience encompasses finance, corporate governance, business transformation, and strategic leadership, aligning with Glenmark's goals for innovation-driven growth.

Ajay Jajoo has joined Glenmark Pharmaceuticals as Group Vice President & Global Corporate Controller. 

Jajoo announced the development in a LinkedIn post, expressing, "Starting my stint with Pharmaceutical Industry Impacting Millions of Life Globally on a Daily basis. This itself is passionately fulfilling & also filled with larger Purpose. The organisation is taking steps into phase 3.0 with Major Transformation Drives for Stakeholder Value Creation led by Science based Innovative Drugs. Looking forward to contributing alongside the globally respected strong & professional Team.”

Prior to joining Glenmark Pharmaceuticals, Jajoo served as President and Chief Financial Officer at Deepak Phenolics Limited. Over the course of his career, he has held senior leadership positions across diverse industries, including stints with Sterlite Technologies Limited, copper mining operations in Tanzania, and Vedanta Ltd, among others.

With extensive experience in finance, corporate governance, business transformation, and strategic leadership, Jajoo's appointment comes as Glenmark Pharmaceuticals continues to strengthen its focus on innovation-driven growth and stakeholder value creation.

Published On: Jun 2, 2026 2:19 PM